Designed by Marcel Breuer in 1928, the Cesca chair was groundbreaking for its use of materials. Its sleek, cantilevered form ...

Century Therapeutics, Inc. (NASDAQ: IPSC) announced that its management team will host a live fireside chat on Tuesday, April ...

Norgine is pleased to announce that the Australian Therapeutic Goods Administration (TGA) has approved the registration of IFINWIL® (eflornithine) for the treatment of adults and paediatric patients ...

Century Therapeutics (NASDAQ:IPSC – Free Report) had its target price cut by HC Wainwright from $5.00 to $2.00 in a research report report published on Thursday morning,Benzinga reports.

H.C. Wainwright lowered the firm’s price target on Century Therapeutics (IPSC) to $2 from $5 and keeps a Buy rating on the shares following the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Prime to present seven studies and receive the 2024 JMCP Award for Excellence "Prime's second-year study on the real-world impact of GLP-1 drugs for obesity showed both low adherence and increased ...

Sybil Schneiderman, the breakout character on Hulu’s new sitcom “Mid-Century Modern,” is discussed, amply, before she is seen. “The woman could probably make it another 20 years just on ...

While Hulu‘s new sitcom Mid-Century Modern explores the bittersweet beauty of life, love and loss, the cast and creators experienced all three in the making of its first season. After co-star ...

A month has gone by since the last earnings report for Beam Therapeutics Inc. (BEAM). Shares have lost about 21.4% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

The US has had a military presence in Greenland since World War II. But an abandoned underground military site poses a major environmental threat as the planet warms. Researchers found thousands ...

The Motley Fool has positions in and recommends Merck and Summit Therapeutics. The Motley Fool has a disclosure policy. 2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a ...